US regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions. Read the story: https://str.sg/JLY6
The US Food and Drug Administration (FDA) on Monday (November 9) granted the emergency use of the first experimental antibody treatment for Covid-19.
Eli Lilly’s bamlanivimab is a monoclonal antibody, or a synthetic copy of an antibody used by the immune system to fight infection.
SUBSCRIBE ➤ http://bit.ly/FollowST
WEBSITE ➤ http://www.straitstimes.com
TWITTER ➤ https://www.twitter.com/STcom
FACEBOOK ➤ https://www.facebook.com/TheStraitsTimes
INSTAGRAM ➤ https://www.instagram.com/straits_times
PODCASTS ➤ https://www.straitstimes.com/st-podcasts
TELEGRAM ➤ https://t.me/straitstimes
The Straits Times, the English flagship daily of SPH, has been serving readers for more than a century. Launched on July 15, 1845, its comprehensive coverage of world news, East Asian news, Southeast Asian news, home news, sports news, financial news and lifestyle updates makes The Straits Times the most-read newspaper in Singapore.